India likely to cut Monsanto’s royalty for GMO insect-resistant Bt cotton seeds

Bollgard II seed Pack x

In an attempt to offer some respite to cotton farmers battered by repeated pest attacks and crop losses, the centre is likely to slash the price of genetically modified Bt cotton seeds as well as trait fees payable by domestic seed companies to technology developers.

The maximum sale price of a Bt cotton (Bollgard II) seed packet weighing 450g is likely to be reduced from Rs800 to Rs740, said a person familiar with the development, requesting anonymity.

The person added that the trait or royalty fee included in the sale price (which domestic seed companies pay to the technology developers) is likely to be reduced from Rs49 per packet to Rs39 per packet.

The committee has unanimously recommended that the government slash seed prices to Rs740 per packet and the agriculture ministry is expected to take a final call soon, said a member of the price control committee, who did not want to be named.

While the move will benefit nearly 8 million cotton growers in India, domestic seed companies will see their earnings fall by at least Rs50 per packet. Technology developer Monsanto Mahyco Biotech (India) Ltd will earn Rs10 less for each packet of cotton seeds sold in India.

Read full, original post: Govt likely to slash Bt Cotton seed price to Rs740 per packet

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-06-17-at-12.31.01-PM
Viewpoint: The dangerous influence of ‘woke’ post-modernism in science
Screenshot-2026-06-26-at-10.14.50-AM
Viewpoint: The facts behind the grifter-promoting wellness and anti-aging peptide craze: Don’t waste your money
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Jun-19-2026-04_11_20-PM
Daubert for Dummies—Scientific Reliability in U.S. Courts: Daubert, Rule 702, and Made-for-Litigation Evidence
ChatGPT-Image-Jun-17-2026-10_52_43-AM
Anguished parents, doctors in tears: Utah’s long measles outbreak takes a toll
ChatGPT-Image-Jun-26-2026-12_10_16-PM
Europe’s heat wave fueled recycled climate-denial narratives and harassment of climate scientists
ChatGPT-Image-Jun-26-2026-01_21_33-PM
How the dubious, Trump-backed, addictive drug kratom could enrich cabinet secretary Markwayne Mullin
Screenshot-2026-06-22-at-9.04.46-PM
Kennedy's nutrition prescription for medical schools: Real problem, bad cure
Screenshot-2026-06-25-at-11.18.03-AM
Viewpoint: Appreciating a simpler past without swallowing the misleading ‘nature is healthier and safer’ myth
ChatGPT-Image-Jun-22-2026-01_30_11-PM
Facts & Fallacies podcast: Psychedelics for PTSD? Examining RFK, Jr's claims about ibogaine
ChatGPT-Image-Jun-26-2026-11_34_33-AM
Viewpoint: RFK, Jr.’s vaccine subterfuge campaign now flies below the media radar
Screenshot-2026-06-15-at-1.55.27-PM
America's trust in Trump-Kennedy's CDC health recommendations is plunging
ChatGPT-Image-Jun-23-2026-03_12_23-PM
Is cellular reprogramming junk science? Nearly 20 patients are getting eye injections in the first FDA-cleared cellular trial
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.